Contact
searchSearch
HMP Global

Skin Cancer Topic Center

Featured

skin cancer
News
Phase 3 Trial Demonstrates Significant Benefits of Libtayo in High-Risk Cutaneous Squamous Cell Carcinoma
01/14/2025
Jessica Garlewicz
Regeneron Pharmaceuticals has announced promising interim results from the Phase 3 C-POST trial, evaluating the PD-1 inhibitor Libtayo (cemiplimab).
Regeneron Pharmaceuticals has announced promising interim results from the Phase 3 C-POST trial, evaluating the PD-1 inhibitor Libtayo (cemiplimab).
Regeneron Pharmaceuticals has...
01/14/2025
The Dermatologist
doctor
News
Pongamia Pinnata Extract as a Potential Treatment for Skin Cancer
12/30/2024
Riya Gandhi, MA
New research reveals Pongamia pinnata’s powerful potential as an anti-cancer agent for skin tumors, combining traditional knowledge with cutting-edge molecular science.
New research reveals Pongamia pinnata’s powerful potential as an anti-cancer agent for skin tumors, combining traditional knowledge with cutting-edge molecular science.
New research reveals Pongamia...
12/30/2024
The Dermatologist
skin cancer
News
Non-Melanoma Skin Cancer Event Rates: Considerations for Clinical Trial Design
08/22/2024
Jessica Garlewicz
Researchers investigated clinical risk factors and event rates for the development of new non-melanoma skin cancer.
Researchers investigated clinical risk factors and event rates for the development of new non-melanoma skin cancer.
Researchers investigated...
08/22/2024
The Dermatologist
skin cancer
News
Skin Cancers Associated with Genodermatoses in Patients with Skin of Color
08/09/2024
Jessica Garlewicz
Researchers aimed to identify notable characteristics in location, frequency, and severity of cutaneous findings, along with the median age of skin cancers in patients with skin of color.
Researchers aimed to identify notable characteristics in location, frequency, and severity of cutaneous findings, along with the median age of skin cancers in patients with skin of color.
Researchers aimed to identify...
08/09/2024
The Dermatologist
skin cancer
News
Esophageal Squamous Cell Carcinoma Under Iodine Staining
08/09/2024
Jessica Garlewicz
Researchers aimed to evaluate the effects of texture and color enhancement imaging on improving the endoscopic visibility of esophageal squamous cell carcinoma under iodine staining.
Researchers aimed to evaluate the effects of texture and color enhancement imaging on improving the endoscopic visibility of esophageal squamous cell carcinoma under iodine staining.
Researchers aimed to evaluate...
08/09/2024
The Dermatologist
skin cancer
News
Establishing a Novel Model for Studying Neural Invasion in Non-Melanoma Skin Cancer
05/15/2024
Jessica Garlewicz
Researchers aimed to develop a 3-dimensional model of neural invasion in squamous cell carcinoma to better understand its underlying biologic mechanisms, which are still poorly understood.
Researchers aimed to develop a 3-dimensional model of neural invasion in squamous cell carcinoma to better understand its underlying biologic mechanisms, which are still poorly understood.
Researchers aimed to develop a...
05/15/2024
The Dermatologist
skin cancer
News
Interferon-Gamma as a Prognostic Marker in Macroscopic Stage III Melanoma
05/08/2024
Jessica Garlewicz
Researchers aimed to identify prognostic and predictive biomarkers for adjuvant anti-PD-1 therapy in patients with macroscopic stage III melanoma.
Researchers aimed to identify prognostic and predictive biomarkers for adjuvant anti-PD-1 therapy in patients with macroscopic stage III melanoma.
Researchers aimed to identify...
05/08/2024
The Dermatologist
skin cancer
News
Relationship Between Insulin Use, Social Determinants of Health, and Non-Melanoma Skin Cancer
05/07/2024
Jessica Garlewicz
Researchers aimed to investigate the relationship between insulin use, social determinants of health, and non-melanoma skin cancer risk among individuals with diabetes.
Researchers aimed to investigate the relationship between insulin use, social determinants of health, and non-melanoma skin cancer risk among individuals with diabetes.
Researchers aimed to investigate...
05/07/2024
The Dermatologist
skin cancer
News
Regulatory T Cell Involvement in Melanoma Prognosis and Treatment Strategy
03/28/2024
Jessica Garlewicz
Researchers analyzed single-cell RNA sequencing data alongside clinical information.
Researchers analyzed single-cell RNA sequencing data alongside clinical information.
Researchers analyzed single-cell...
03/28/2024
The Dermatologist
skin cancer
News
Role of Cuproptosis and Hippo Pathway in the Prognosis of Skin Cutaneous Melanoma
03/28/2024
Jessica Garlewicz
Researchers examined the correlation between cuproptosis-related and Hippo pathway-related genes and melanoma prognosis using public databases and experimental validation.
Researchers examined the correlation between cuproptosis-related and Hippo pathway-related genes and melanoma prognosis using public databases and experimental validation.
Researchers examined the...
03/28/2024
The Dermatologist
skin cancer
News
Utilization of Hybrid Topological Data Analysis and Deep Learning for Basal Cell Carcinoma Diagnosis
02/15/2024
Jessica Garlewicz
Researchers introduced a novel approach by combining topological data analysis (TDA) and deep learning (DL) through ensemble learning to develop a hybrid TDA-DL basal cell carcinoma diagnostic model.
Researchers introduced a novel approach by combining topological data analysis (TDA) and deep learning (DL) through ensemble learning to develop a hybrid TDA-DL basal cell carcinoma diagnostic model.
Researchers introduced a novel...
02/15/2024
The Dermatologist

Case Reports

DID Reviewed Article
Shedding Light on Precancers
10/15/2021
Tristan M Hasbargen, MMS, PA-C
Photodynamic therapy (PDT) was a popular dermatologic treatment more than 100 years ago until newer medications came to market. Recent studies of PDT have shown some efficacy of treating actinic keratoses.
Photodynamic therapy (PDT) was a popular dermatologic treatment more than 100 years ago until newer medications came to market. Recent studies of PDT have shown some efficacy of treating actinic keratoses.
Photodynamic therapy (PDT) was a...
10/15/2021
The Dermatologist
Derm Dx
What Syndrome Caused These Palmar Pits?
09/15/2021
Melissa A. Nickles, BA; Kurt A. Ashack, MD, MHS; Amor Khachemoune, MD, FAAD, FACMS
A 14-year-old Hispanic boy presented to the dermatology clinic with multiple asymptomatic, circular indentations on both palms after immersing his hands in water.
A 14-year-old Hispanic boy presented to the dermatology clinic with multiple asymptomatic, circular indentations on both palms after immersing his hands in water.
A 14-year-old Hispanic boy...
09/15/2021
The Dermatologist
Feature Story
Using Ancillary Tests in the Diagnosis of Melanoma
09/15/2021
Linda Susan Marcus, MD, FAAD
Novel diagnostic tests may be useful in helping to detect malignancy, particularly if the test can be used by the patient remotely. Like any new therapy or technique, these tests need more study to determine their clinical utility for...
Novel diagnostic tests may be useful in helping to detect malignancy, particularly if the test can be used by the patient remotely. Like any new therapy or technique, these tests need more study to determine their clinical utility for...
Novel diagnostic tests may be...
09/15/2021
The Dermatologist
Feature Story
Mohs Surgery in a Post-COVID World: Improving Patient Outcomes in 2021
08/16/2021
Jeremy Youse, MD
Personal ancedotes and published research are starting to explore how the pandemic may have impacted skin cancer diagnosis and care. Dermatologists have to take an active role in patient outreach to improve downstream outcomes.
Personal ancedotes and published research are starting to explore how the pandemic may have impacted skin cancer diagnosis and care. Dermatologists have to take an active role in patient outreach to improve downstream outcomes.
Personal ancedotes and published...
08/16/2021
The Dermatologist
Derm Dx
What Is This Papule?
07/11/2021
Sabrina Lichon Bennett, MD; Amor Khachemoune, MD, FAAD, FACMS; Vanessa Lichon, MD; Karl Napekoski, MD
A 33-year-old woman presented to the clinic complaining of a “firm spot” on her left cheek that rapidly grew and stabilized over the course of approximately 6 weeks.
A 33-year-old woman presented to the clinic complaining of a “firm spot” on her left cheek that rapidly grew and stabilized over the course of approximately 6 weeks.
A 33-year-old woman presented to...
07/11/2021
The Dermatologist
Derm Dx
What Is the Underlying Cause of These Exophytic Lesions?
05/09/2021
A 102-year-old African American woman presented to the dermatology clinic for initial management of lesions on her right medial foot. The lesions had been present for several weeks, and the patient was unable to recall any preceding trauma,...
A 102-year-old African American woman presented to the dermatology clinic for initial management of lesions on her right medial foot. The lesions had been present for several weeks, and the patient was unable to recall any preceding trauma,...
A 102-year-old African American...
05/09/2021
The Dermatologist
Feature Story
Office-Based Surface Radiotherapy for the Dermatology Clinic: A Two-Case Study
03/12/2021
Steven A. Davis, MD
Standard of care for patients with nonmelanoma skin cancer (NMSC) remains to be surgical treatment. A number of techniques, including standard excision, Mohs micrographic surgery, and electrodesiccation and...
Standard of care for patients with nonmelanoma skin cancer (NMSC) remains to be surgical treatment. A number of techniques, including standard excision, Mohs micrographic surgery, and electrodesiccation and...
...
03/12/2021
The Dermatologist
Derm Dx
What Is This Hyperpigmented Scalp Nodule?
03/11/2021
Karen Heidelberg, MD; Adam Richardson, DO; Ciara Grayson, MD, MS
Figure 1 Case Report A 75-year-old African American woman presented to the clinic with a history of a slowly growing asymptomatic nodule on the right anterior scalp over a few months. Physical exam...
Figure 1 Case Report A 75-year-old African American woman presented to the clinic with a history of a slowly growing asymptomatic nodule on the right anterior scalp over a few months. Physical exam...
...
03/11/2021
The Dermatologist
Feature Story
Primary Cutaneous Myoepithelial Carcinoma Discovered Incidentally During Mohs Surgery
02/16/2021
Pavan K. Nootheti, MD, FAAD, FACMS; Vassiliki Papastavros, MD
Primary cutaneous myoepithelial carcinoma is very rare, with fewer than 15 cases reported in the literature to date. In our patient, primary cutaneous myoepithelial carcinoma was discovered incidentally during Mohs...
Primary cutaneous myoepithelial carcinoma is very rare, with fewer than 15 cases reported in the literature to date. In our patient, primary cutaneous myoepithelial carcinoma was discovered incidentally during Mohs...
...
02/16/2021
The Dermatologist
Feature Story
A Tender Eyebrow Nodule Heralding the Malignant Degeneration of a Spiradenoma
12/14/2020
Tesia Kolodziejczyk, BA
While uncommon, the diagnosis and treatment of cutaneous adnexal tumors such as spiradenocarcinoma are incredibly important for prognostic implications.   Spiradenocarcinomas are rare, malignant eccrine tumors...
While uncommon, the diagnosis and treatment of cutaneous adnexal tumors such as spiradenocarcinoma are incredibly important for prognostic implications.   Spiradenocarcinomas are rare, malignant eccrine tumors...
...
12/14/2020
The Dermatologist
Derm Dx
What Caused These Changes on the Shins?
01/30/2026
Bruh Alem, MD; Aklilu Melaku, MD; Amor Khachemoune, MD, FAAD, FACMS
A 72-year-old man with a history of type 2 diabetes, obesity, and hypertension presented with multiple firm, well-circumscribed, reddish-brown, cystic lesions on both shins but more pronounced on his right shin.
A 72-year-old man with a history of type 2 diabetes, obesity, and hypertension presented with multiple firm, well-circumscribed, reddish-brown, cystic lesions on both shins but more pronounced on his right shin.
A 72-year-old man with a history...
01/30/2026
The Dermatologist
Derm Dx
What Is This Process That Occurs in Hairdressers?
12/09/2025
Kassidy Fishman, BBA; Stephanie Liu, DO, MBA; Robert Adler, BA; Isha Gandhi, BS; Robert Phelps, MD
A 57-year-old man who works as barber presented with a nodule on his dorsal right hand.
A 57-year-old man who works as barber presented with a nodule on his dorsal right hand.
A 57-year-old man who works as...
12/09/2025
The Dermatologist
Derm Dx
What Is This Lesion on an Older Woman’s Finger?
10/09/2025
Aaisha Jamiluddin, MS; Vrinda Deshpande, MS; Bryan Ebert, MD; Nasir Aziz, MD
An 84-year-old woman presented for evaluation of a purple lesion on her left index finger.
An 84-year-old woman presented for evaluation of a purple lesion on her left index finger.
An 84-year-old woman presented...
10/09/2025
The Dermatologist
Feature Story
Monitoring Patients on Systemic Treatments: Deucravacitinib
10/06/2025
Dina Collins, MD, MS; Chenan Andy Huang, MD; Kristina Callis-Duffin, MD, MS; Shari Lipner, MD, PhD; Bruce E. Strober, MD, PhD; Steven R. Feldman, MD, PhD
This new series presents practical, concise guidance for monitoring specific systemic drugs. In this article, dermatologists share their approach to the oral Janus kinase inhibitor deucravacitinib for patients with moderate-to-severe plaque...
This new series presents practical, concise guidance for monitoring specific systemic drugs. In this article, dermatologists share their approach to the oral Janus kinase inhibitor deucravacitinib for patients with moderate-to-severe plaque...
This new series presents...
10/06/2025
The Dermatologist
MASTERCLASSES IN DERMATOLOGY FORUM
Redefining Remission and Low Disease Activity in Dermatology
10/06/2025
Joseph F. Merola, MD, MMSc; Alice Bendix Gottlieb, MD, PhD
Remission is no longer an abstract dream; it is the evolving standard we must pursue with clarity, creativity, and urgency.
Remission is no longer an abstract dream; it is the evolving standard we must pursue with clarity, creativity, and urgency.
Remission is no longer an...
10/06/2025
The Dermatologist
Derm Dx
What Is This Pigmented Lesion?
09/10/2025
Turkan Banu Karatas, MD; Katie Roster, MD; Banu Farabi, MD; Mehmet Fatih Atak, MD; Shoshana Marmon, MD, PhD
A 63-year-old man with Fitzpatrick skin type III presented to clinic with an asymptomatic 6-mm x 6-mm, brown-black, asymmetric macule and surrounding light brown patch on the left anterior upper arm.
A 63-year-old man with Fitzpatrick skin type III presented to clinic with an asymptomatic 6-mm x 6-mm, brown-black, asymmetric macule and surrounding light brown patch on the left anterior upper arm.
A 63-year-old man with...
09/10/2025
The Dermatologist
Feature Story
Two Roads Diverging: The Future of Patient Communication in the Era of Artificial Intelligence
09/08/2025
Ross Lane Pearlman, MD
Without a doubt, the rise of large language model applications will affect the dialogue between patients and physicians.
Without a doubt, the rise of large language model applications will affect the dialogue between patients and physicians.
Without a doubt, the rise of...
09/08/2025
The Dermatologist
HSF Reviewed Features
Optimizing HS Visits: A Dermatologist’s Guide to Compassionate, Effective Care
09/08/2025
Gretchen M. Roth, MD, FAAD; Precious A. Anyanwu
Together, we can improve hidradenitis suppurativa care and help improve the lives of our patients.
Together, we can improve hidradenitis suppurativa care and help improve the lives of our patients.
Together, we can improve...
09/08/2025
The Dermatologist
Feature Story
GLP-1 Agonists: Implications for Dermatology
08/02/2025
Serene Majid, BA; Steven R. Feldman, MD, PhD
This article provides an accessible overview of the pharmacologic mechanisms of glucagon-like peptide-1 receptor agonists, the utility of these drugs in obesity, and their potential applications in managing inflammatory skin disease.
This article provides an accessible overview of the pharmacologic mechanisms of glucagon-like peptide-1 receptor agonists, the utility of these drugs in obesity, and their potential applications in managing inflammatory skin disease.
This article provides an...
08/02/2025
The Dermatologist
Derm Dx
What Is This Yellowish, Erythematous Papule?
08/02/2025
Angelique Ruml, BS; Ibeth Caceres, BS; Joan Fernandez, MD; Eleanor Workman, MD; Yve T. Huttenbach, MD; Ikue Shimizu, MD; Jennifer S. Ranario, MD, MBA
A 91-year-old African American man presented to the dermatology clinic for evaluation of a small, painless papule on his left eyelid of unknown duration.
A 91-year-old African American man presented to the dermatology clinic for evaluation of a small, painless papule on his left eyelid of unknown duration.
A 91-year-old African American...
08/02/2025
The Dermatologist

Expert Insights

Dr Manuel Valdebran
Q&As
Sun Protective Behaviors Associated With Family History of Melanoma
04/10/2023
Riya Gandhi, MA
In this interview, Dr Manuel Valdebran discusses the association between sun protective behaviors and family history of melanoma, along with the importance of recommending alternate SPB in addition to sunscreen use.
In this interview, Dr Manuel Valdebran discusses the association between sun protective behaviors and family history of melanoma, along with the importance of recommending alternate SPB in addition to sunscreen use.
In this interview, Dr Manuel...
04/10/2023
The Dermatologist
Vernon Sondak
Q&As
Latest Advances in Melanoma Treatment
03/31/2023
Riya Gandhi, MA
In this interview, The Dermatologist met with Dr Vernon Sondak to discuss his recent session, “Update on the Latest Advances in Treatment of Melanoma,” at the 2023 AAD Annual Meeting.
In this interview, The Dermatologist met with Dr Vernon Sondak to discuss his recent session, “Update on the Latest Advances in Treatment of Melanoma,” at the 2023 AAD Annual Meeting.
In this interview, The...
03/31/2023
The Dermatologist
Dr Julia Siegel
Videos
Conversations About Photoprotection During the Pandemic
10/21/2021
Julia A. Siegel, MD
Dr Julia Siegel discusses the importance of photoprotection, sunscreen, and how the pandemic has affected patient skin exams.
Dr Julia Siegel discusses the importance of photoprotection, sunscreen, and how the pandemic has affected patient skin exams.
Dr Julia Siegel discusses the...
10/21/2021
The Dermatologist
DID Reviewed Article
Shedding Light on Precancers
10/15/2021
Tristan M Hasbargen, MMS, PA-C
Photodynamic therapy (PDT) was a popular dermatologic treatment more than 100 years ago until newer medications came to market. Recent studies of PDT have shown some efficacy of treating actinic keratoses.
Photodynamic therapy (PDT) was a popular dermatologic treatment more than 100 years ago until newer medications came to market. Recent studies of PDT have shown some efficacy of treating actinic keratoses.
Photodynamic therapy (PDT) was a...
10/15/2021
The Dermatologist
Feature Story
Using Ancillary Tests in the Diagnosis of Melanoma
09/15/2021
Linda Susan Marcus, MD, FAAD
Novel diagnostic tests may be useful in helping to detect malignancy, particularly if the test can be used by the patient remotely. Like any new therapy or technique, these tests need more study to determine their clinical utility for...
Novel diagnostic tests may be useful in helping to detect malignancy, particularly if the test can be used by the patient remotely. Like any new therapy or technique, these tests need more study to determine their clinical utility for...
Novel diagnostic tests may be...
09/15/2021
The Dermatologist
Feature Story
Mohs Surgery in a Post-COVID World: Improving Patient Outcomes in 2021
08/16/2021
Jeremy Youse, MD
Personal ancedotes and published research are starting to explore how the pandemic may have impacted skin cancer diagnosis and care. Dermatologists have to take an active role in patient outreach to improve downstream outcomes.
Personal ancedotes and published research are starting to explore how the pandemic may have impacted skin cancer diagnosis and care. Dermatologists have to take an active role in patient outreach to improve downstream outcomes.
Personal ancedotes and published...
08/16/2021
The Dermatologist
Dr Goyal-O’Leary on mycosis fungoides and melanoma
Videos
Mycosis Fungoides and Melanoma: Insights for Derm
07/13/2021
In this video Dr Goyal shares her unique tips and insights for fellow dermatologists regarding mycosis fungoides and melanoma.
In this video Dr Goyal shares her unique tips and insights for fellow dermatologists regarding mycosis fungoides and melanoma.
In this video Dr Goyal shares...
07/13/2021
The Dermatologist
Q&As
Melanoma: On the Cusp of New Advances
05/17/2021
Jessica Garlewicz
Just over the horizon of melanoma diagnosis and treatment are a number of exciting opportunities, from prevention therapeutics to telehealth. Dr Sancy Leachman shares her perspective.
Just over the horizon of melanoma diagnosis and treatment are a number of exciting opportunities, from prevention therapeutics to telehealth. Dr Sancy Leachman shares her perspective.
Just over the horizon of...
05/17/2021
The Dermatologist
Cover Story
The Fight for Photoprotection: Pushing for Increased Sunscreen Access
05/11/2021
Lauren Mateja
Photoprotection is a critical part of basic skin care, let alone skin cancer prevention. Improving access to sunscreen products, particularly when it comes to travel, could mean improved outcomes for all patients.
Photoprotection is a critical part of basic skin care, let alone skin cancer prevention. Improving access to sunscreen products, particularly when it comes to travel, could mean improved outcomes for all patients.
Photoprotection is a critical...
05/11/2021
The Dermatologist
Feature Story
Office-Based Surface Radiotherapy for the Dermatology Clinic: A Two-Case Study
03/12/2021
Steven A. Davis, MD
Standard of care for patients with nonmelanoma skin cancer (NMSC) remains to be surgical treatment. A number of techniques, including standard excision, Mohs micrographic surgery, and electrodesiccation and...
Standard of care for patients with nonmelanoma skin cancer (NMSC) remains to be surgical treatment. A number of techniques, including standard excision, Mohs micrographic surgery, and electrodesiccation and...
...
03/12/2021
The Dermatologist
Melissa Piliang
Videos
Managing Eyebrow & Eyelash Loss in Alopecia Areata: Emotional Impact & Treatment Insights
02/01/2026
Melissa Piliang, MD
In an insightful conversation with Dr Melissa Piliang, we explore how eyebrow and eyelash loss affects patients’ quality of life, advancements in treatment options, and how new clinical trials are offering hope for patients seeking eyebrow...
In an insightful conversation with Dr Melissa Piliang, we explore how eyebrow and eyelash loss affects patients’ quality of life, advancements in treatment options, and how new clinical trials are offering hope for patients seeking eyebrow...
In an insightful conversation...
02/01/2026
The Dermatologist
Cover Story
Forward Focus: Top Trends in Dermatology for 2026
01/30/2026
Joseph F. Merola, MD, MMSc; Alice Bendix Gottlieb, MD, PhD
From low disease activity and remission to digital measurement, equity, and access, Dr Joseph Merola and Dr Alice Gottlieb map where dermatology is heading next.
From low disease activity and remission to digital measurement, equity, and access, Dr Joseph Merola and Dr Alice Gottlieb map where dermatology is heading next.
From low disease activity and...
01/30/2026
The Dermatologist
Peter Lio
Clinical Insights
Urbanization, Lifestyle, and Skin Barrier Damage in Atopic Dermatitis
01/20/2026
Peter Lio, MD, FAAD
Dr Peter Lio discusses how urbanization, modern lifestyles, and shifting environmental exposures may be driving rising rates of allergic rhinitis, food allergy, and atopic dermatitis—and which exposures should most concern clinicians.
Dr Peter Lio discusses how urbanization, modern lifestyles, and shifting environmental exposures may be driving rising rates of allergic rhinitis, food allergy, and atopic dermatitis—and which exposures should most concern clinicians.
Dr Peter Lio discusses how...
01/20/2026
Allergy & Immunology
Stephen D. Hess, MD, PhD
Videos
Electrical Impedance Spectroscopy For Skin Cancer Screening
01/13/2026
Stephen D. Hess, MD, PhD
Dr Stephen Hess shares how he integrates the augmented intelligence-based Nevisense device into real-world dermatology practice to enhance clinical decision-making.
Dr Stephen Hess shares how he integrates the augmented intelligence-based Nevisense device into real-world dermatology practice to enhance clinical decision-making.
Dr Stephen Hess shares how he...
01/13/2026
The Dermatologist
melissa Piliang
Videos
JAK Inhibitors & Boxed Warnings
12/17/2025
Melissa Piliang, MD
Gain expert insight into the origins and implications of the boxed warning on JAK inhibitors for dermatologists treating alopecia areata. Learn about clinical trial data, patient selection, risk mitigation strategies, and the importance of...
Gain expert insight into the origins and implications of the boxed warning on JAK inhibitors for dermatologists treating alopecia areata. Learn about clinical trial data, patient selection, risk mitigation strategies, and the importance of...
Gain expert insight into the...
12/17/2025
The Dermatologist
Cover Story
Redefining the Standard: Adjuvant and Neoadjuvant Immunotherapy in High-Risk, Advanced CSCC
12/09/2025
Vishal A Patel, MD
With new data supporting adjuvant cemiplimab and promising outcomes from neoadjuvant strategies, immunotherapy is reshaping the treatment landscape for high-risk and advanced cutaneous squamous cell carcinoma.
With new data supporting adjuvant cemiplimab and promising outcomes from neoadjuvant strategies, immunotherapy is reshaping the treatment landscape for high-risk and advanced cutaneous squamous cell carcinoma.
With new data supporting...
12/09/2025
The Dermatologist
Part 3
Q&As
Rebuilding Confidence in Alopecia Areata: Multidisciplinary, Holistic Support for Patients and Families
11/03/2025
Brittany Craiglow, MD; Brett A. King, MD, PhD; Maryanne Makredes Senna, MD
Experts explore holistic and emotional support strategies to empower patients with alopecia areata—beyond medicine, toward identity and healing.
Experts explore holistic and emotional support strategies to empower patients with alopecia areata—beyond medicine, toward identity and healing.
Experts explore holistic and...
11/03/2025
The Dermatologist
Part 3
Videos
Part 3: Rebuilding Confidence: Multidisciplinary and Holistic Approaches to Severe Alopecia Areata
11/03/2025
Brittany Craiglow, MD; Brett A. King, MD, PhD; Maryanne Makredes Senna, MD
In the final installment of this expert roundtable series, top dermatologists discuss holistic care in alopecia areata, including emotional support, patient education, and resources like the National Alopecia Areata Foundation. Learn how to...
In the final installment of this expert roundtable series, top dermatologists discuss holistic care in alopecia areata, including emotional support, patient education, and resources like the National Alopecia Areata Foundation. Learn how to...
In the final installment of this...
11/03/2025
The Dermatologist
Cover Story
Chronic Hand Eczema: Breaking Out of the Atopic Dermatitis Umbrella
10/06/2025
Jeff Yu, MD
This condition may be far more common and burdensome than previously recognized in US dermatologic practice.
This condition may be far more common and burdensome than previously recognized in US dermatologic practice.
This condition may be far more...
10/06/2025
The Dermatologist
Feature Story
Monitoring Patients on Systemic Treatments: Deucravacitinib
10/06/2025
Dina Collins, MD, MS; Chenan Andy Huang, MD; Kristina Callis-Duffin, MD, MS; Shari Lipner, MD, PhD; Bruce E. Strober, MD, PhD; Steven R. Feldman, MD, PhD
This new series presents practical, concise guidance for monitoring specific systemic drugs. In this article, dermatologists share their approach to the oral Janus kinase inhibitor deucravacitinib for patients with moderate-to-severe plaque...
This new series presents practical, concise guidance for monitoring specific systemic drugs. In this article, dermatologists share their approach to the oral Janus kinase inhibitor deucravacitinib for patients with moderate-to-severe plaque...
This new series presents...
10/06/2025
The Dermatologist

Interactive

skin of color skin examination
Quiz
Trivia: Skin Cancer in Patients With Skin of Color
06/16/2022
Jessica Garlewicz
Are patients with skin of color excluded from getting skin cancer?
Are patients with skin of color excluded from getting skin cancer?
Are patients with skin of color...
06/16/2022
The Dermatologist
squamous cell carcinoma on head
Quiz
Trivia: Risk Factors Associated With Anxiety in Mohs Micrographic Surgery
06/09/2022
Jessica Garlewicz
Which of the following options accurately identifies risk factors associated with anxiety concerning Mohs micrographic surgery?
Which of the following options accurately identifies risk factors associated with anxiety concerning Mohs micrographic surgery?
Which of the following options...
06/09/2022
The Dermatologist
Quiz
Trivia: National Comprehensive Cancer Network Guidelines
06/22/2021
Can you identify which option coincides with the National Comprehensive Cancer Network guidelines supporting Dr Srivastava’s statement?
Can you identify which option coincides with the National Comprehensive Cancer Network guidelines supporting Dr Srivastava’s statement?
Can you identify which option...
06/22/2021
The Dermatologist
eee
Quiz
Pediatric Melanoma Anatomical Site
06/15/2021
Which of the following accurately describes the results of a study published in Laryngoscope?
Which of the following accurately describes the results of a study published in Laryngoscope?
Which of the following...
06/15/2021
The Dermatologist
Quiz
Maximizing Photoprotective Behaviors
04/15/2021
A recent study found that sunscreen use, long-sleeved shirt use, and shade-seeking behavior are inadequate in which two groups?
A recent study found that sunscreen use, long-sleeved shirt use, and shade-seeking behavior are inadequate in which two groups?
A recent study found that...
04/15/2021
The Dermatologist
Quiz
What's Your Dx: Thickened and Discolored Nail
11/13/2020
A 62-year-old White man presented with nail changes on his left third finger. He described an initial thickening and discoloration of his nail of 1 year that progressed more rapidly over the last 12 months to the current presentation. What`s...
A 62-year-old White man presented with nail changes on his left third finger. He described an initial thickening and discoloration of his nail of 1 year that progressed more rapidly over the last 12 months to the current presentation. What`s...
A 62-year-old White man...
11/13/2020
The Dermatologist
Quiz
Initiating JAK Inhibitors in AA: Screening, Safety, and Shared Decision-Making
01/15/2026
Riya Gandhi, MA
Test your knowledge of best practices before initiating JAK inhibitors for alopecia areata.
Test your knowledge of best practices before initiating JAK inhibitors for alopecia areata.
Test your knowledge of best...
01/15/2026
The Dermatologist
Quiz
MACE Risk in Alopecia Areata: What Clinical Trials and Real-World Data Reveal
01/05/2026
Riya Gandhi, MA
This quiz examines which patients experienced MACE events in clinical trials and how real-world incidence data compares.
This quiz examines which patients experienced MACE events in clinical trials and how real-world incidence data compares.
This quiz examines which...
01/05/2026
The Dermatologist
Quiz
Why Higher JAK Doses Raise Safety Concerns in AD
01/01/2026
Riya Gandhi, MA
Dive into kinase dynamics—can you pinpoint the molecular reason behind increased adverse event risk with high-dose JAK inhibitor therapy?
Dive into kinase dynamics—can you pinpoint the molecular reason behind increased adverse event risk with high-dose JAK inhibitor therapy?
Dive into kinase dynamics—can...
01/01/2026
The Dermatologist
Quiz
What Drives Fibrosis in Chronic Atopic Dermatitis Lesions?
01/01/2026
Riya Gandhi, MA
Take the quiz to explore how fibroblasts respond to Type 2 cytokines in long-standing AD.
Take the quiz to explore how fibroblasts respond to Type 2 cytokines in long-standing AD.
Take the quiz to explore how...
01/01/2026
The Dermatologist
Quiz
Alopecia Areata Support Systems, Peer Networks, and Patient Misinformation
12/20/2025
Riya Gandhi, MA
How do you guide patients through peer-driven misinformation and anxiety-provoking online forums? Take this quiz to refine your approach to trusted resources and patient-centered reassurance.
How do you guide patients through peer-driven misinformation and anxiety-provoking online forums? Take this quiz to refine your approach to trusted resources and patient-centered reassurance.
How do you guide patients...
12/20/2025
The Dermatologist
acne
Quiz
Quiz: Acne Topical Therapy
12/18/2025
Jessica Garlewicz
Which advancement in topical acne therapy was highlighted as improving tolerability while maintaining efficacy?
Which advancement in topical acne therapy was highlighted as improving tolerability while maintaining efficacy?
Which advancement in topical...
12/18/2025
The Dermatologist
psoriasis
Quiz
Quiz: Clinical Clue in Psoriasis Diagnosis
12/18/2025
Jessica Garlewicz
What clinical clue should prompt a dermatologist to question the diagnosis of psoriasis, especially when highly effective agents fail?
What clinical clue should prompt a dermatologist to question the diagnosis of psoriasis, especially when highly effective agents fail?
What clinical clue should prompt...
12/18/2025
The Dermatologist
Quiz
Etiological Communication, Atopy, and First-Visit Navigation in AA
12/10/2025
Riya Gandhi, MA
Master the first-visit conversation for AA patients. Quiz yourself on how to balance hope with realism, address comorbid atopy, and respond to the quest for deeper causality in autoimmune disease.
Master the first-visit conversation for AA patients. Quiz yourself on how to balance hope with realism, address comorbid atopy, and respond to the quest for deeper causality in autoimmune disease.
Master the first-visit...
12/10/2025
The Dermatologist
Quiz
Clinical Benefit of Accurate Risk Stratification in cSCC Management
12/04/2025
Jessica Garlewicz
What is the primary clinical benefit of accurate risk stratification in cutaneous squamous cell carcinoma management?
What is the primary clinical benefit of accurate risk stratification in cutaneous squamous cell carcinoma management?
What is the primary clinical...
12/04/2025
The Dermatologist
Quiz
Investigative Urgency and Autoimmune Framing in AA
12/01/2025
Riya Gandhi, MA
Patients often seek extensive testing to “find the root cause” of AA. Take this quiz to sharpen your ability to guide these discussions.
Patients often seek extensive testing to “find the root cause” of AA. Take this quiz to sharpen your ability to guide these discussions.
Patients often seek extensive...
12/01/2025
The Dermatologist

News

skin cancer
News
Phase 3 Trial Demonstrates Significant Benefits of Libtayo in High-Risk Cutaneous Squamous Cell Carcinoma
01/14/2025
Jessica Garlewicz
Regeneron Pharmaceuticals has announced promising interim results from the Phase 3 C-POST trial, evaluating the PD-1 inhibitor Libtayo (cemiplimab).
Regeneron Pharmaceuticals has announced promising interim results from the Phase 3 C-POST trial, evaluating the PD-1 inhibitor Libtayo (cemiplimab).
Regeneron Pharmaceuticals has...
01/14/2025
The Dermatologist
doctor
News
Pongamia Pinnata Extract as a Potential Treatment for Skin Cancer
12/30/2024
Riya Gandhi, MA
New research reveals Pongamia pinnata’s powerful potential as an anti-cancer agent for skin tumors, combining traditional knowledge with cutting-edge molecular science.
New research reveals Pongamia pinnata’s powerful potential as an anti-cancer agent for skin tumors, combining traditional knowledge with cutting-edge molecular science.
New research reveals Pongamia...
12/30/2024
The Dermatologist
skin cancer
News
Non-Melanoma Skin Cancer Event Rates: Considerations for Clinical Trial Design
08/22/2024
Jessica Garlewicz
Researchers investigated clinical risk factors and event rates for the development of new non-melanoma skin cancer.
Researchers investigated clinical risk factors and event rates for the development of new non-melanoma skin cancer.
Researchers investigated...
08/22/2024
The Dermatologist
skin cancer
News
Skin Cancers Associated with Genodermatoses in Patients with Skin of Color
08/09/2024
Jessica Garlewicz
Researchers aimed to identify notable characteristics in location, frequency, and severity of cutaneous findings, along with the median age of skin cancers in patients with skin of color.
Researchers aimed to identify notable characteristics in location, frequency, and severity of cutaneous findings, along with the median age of skin cancers in patients with skin of color.
Researchers aimed to identify...
08/09/2024
The Dermatologist
skin cancer
News
Esophageal Squamous Cell Carcinoma Under Iodine Staining
08/09/2024
Jessica Garlewicz
Researchers aimed to evaluate the effects of texture and color enhancement imaging on improving the endoscopic visibility of esophageal squamous cell carcinoma under iodine staining.
Researchers aimed to evaluate the effects of texture and color enhancement imaging on improving the endoscopic visibility of esophageal squamous cell carcinoma under iodine staining.
Researchers aimed to evaluate...
08/09/2024
The Dermatologist
skin cancer
News
Establishing a Novel Model for Studying Neural Invasion in Non-Melanoma Skin Cancer
05/15/2024
Jessica Garlewicz
Researchers aimed to develop a 3-dimensional model of neural invasion in squamous cell carcinoma to better understand its underlying biologic mechanisms, which are still poorly understood.
Researchers aimed to develop a 3-dimensional model of neural invasion in squamous cell carcinoma to better understand its underlying biologic mechanisms, which are still poorly understood.
Researchers aimed to develop a...
05/15/2024
The Dermatologist
skin cancer
News
Interferon-Gamma as a Prognostic Marker in Macroscopic Stage III Melanoma
05/08/2024
Jessica Garlewicz
Researchers aimed to identify prognostic and predictive biomarkers for adjuvant anti-PD-1 therapy in patients with macroscopic stage III melanoma.
Researchers aimed to identify prognostic and predictive biomarkers for adjuvant anti-PD-1 therapy in patients with macroscopic stage III melanoma.
Researchers aimed to identify...
05/08/2024
The Dermatologist
skin cancer
News
Relationship Between Insulin Use, Social Determinants of Health, and Non-Melanoma Skin Cancer
05/07/2024
Jessica Garlewicz
Researchers aimed to investigate the relationship between insulin use, social determinants of health, and non-melanoma skin cancer risk among individuals with diabetes.
Researchers aimed to investigate the relationship between insulin use, social determinants of health, and non-melanoma skin cancer risk among individuals with diabetes.
Researchers aimed to investigate...
05/07/2024
The Dermatologist
skin cancer
News
Regulatory T Cell Involvement in Melanoma Prognosis and Treatment Strategy
03/28/2024
Jessica Garlewicz
Researchers analyzed single-cell RNA sequencing data alongside clinical information.
Researchers analyzed single-cell RNA sequencing data alongside clinical information.
Researchers analyzed single-cell...
03/28/2024
The Dermatologist
skin cancer
News
Role of Cuproptosis and Hippo Pathway in the Prognosis of Skin Cutaneous Melanoma
03/28/2024
Jessica Garlewicz
Researchers examined the correlation between cuproptosis-related and Hippo pathway-related genes and melanoma prognosis using public databases and experimental validation.
Researchers examined the correlation between cuproptosis-related and Hippo pathway-related genes and melanoma prognosis using public databases and experimental validation.
Researchers examined the...
03/28/2024
The Dermatologist
psoriasis
News
Low Prevalence but Meaningful Impact of Psychological Symptoms Seen in Well-Controlled Psoriasis
02/03/2026
Jessica Garlewicz
Anxiety and depression symptoms can still occur in young adults with well-controlled psoriasis, even when disease activity is minimal, according to a cross-sectional study exploring psychological distress and its potential biological...
Anxiety and depression symptoms can still occur in young adults with well-controlled psoriasis, even when disease activity is minimal, according to a cross-sectional study exploring psychological distress and its potential biological...
Anxiety and depression symptoms...
02/03/2026
The Dermatologist
psoriasis
News
Mathematical Modeling Study Highlights Cytokine Balance and Stem Cell Feedback in Psoriasis Control
01/22/2026
Jessica Garlewicz
A new systems biology study using mathematical modeling provides insight into how cytokine imbalance drives psoriasis flares and suggests that restoring immune-epidermal feedback.
A new systems biology study using mathematical modeling provides insight into how cytokine imbalance drives psoriasis flares and suggests that restoring immune-epidermal feedback.
A new systems biology study...
01/22/2026
The Dermatologist
Cutaneous Squamous Cell Carcinoma
News
Managing Cutaneous Squamous Cell Carcinoma
01/06/2026
Jessica Garlewicz
An updated evidence-based review outlines contemporary strategies for evaluating and managing cutaneous squamous cell carcinoma.
An updated evidence-based review outlines contemporary strategies for evaluating and managing cutaneous squamous cell carcinoma.
An updated evidence-based review...
01/06/2026
The Dermatologist
Atopic dermatitis
FDA Alerts
FDA Approves Roflumilast Cream 0.05% for Treatment of Atopic Dermatitis in Children Aged 2 to 5
10/06/2025
Riya Gandhi, MA
On October 6, 2025, the US FDA approved ZORYVE (roflumilast) cream 0.05% for the topical treatment of mild-to-moderate atopic dermatitis in pediatric patients aged 2 to 5 years.
On October 6, 2025, the US FDA approved ZORYVE (roflumilast) cream 0.05% for the topical treatment of mild-to-moderate atopic dermatitis in pediatric patients aged 2 to 5 years.
On October 6, 2025, the US FDA...
10/06/2025
The Dermatologist
AD
FDA Alerts
FDA Approves Opzelura for Atopic Dermatitis in Children Aged 2–11
09/18/2025
Riya Gandhi, MA
US FDA approved Opzelura (ruxolitinib) cream 1.5% for the short-term and noncontinuous chronic treatment of mild-to-moderate AD in nonimmunocompromised children aged 2 years and older.
US FDA approved Opzelura (ruxolitinib) cream 1.5% for the short-term and noncontinuous chronic treatment of mild-to-moderate AD in nonimmunocompromised children aged 2 years and older.
US FDA approved Opzelura...
09/18/2025
The Dermatologist
FDA Alerts
Anzupgo Available for Prescribing Today
09/08/2025
Coleen Stern, MA
FDA recently approved delgocitinib cream as the first and only treatment indicated for moderate-to-severe chronic hand eczema in adults.
FDA recently approved delgocitinib cream as the first and only treatment indicated for moderate-to-severe chronic hand eczema in adults.
FDA recently approved...
09/08/2025
The Dermatologist
psoriatic arthritis
News
Rare Case Highlights Diagnostic and Treatment Challenges in PsA–Myopathy Overlap
09/02/2025
Jessica Garlewicz
The case study, accompanied by a review of 17 similar reports, details shared immunopathogenesis and conflicting treatment responses in this rare overlap syndrome.
The case study, accompanied by a review of 17 similar reports, details shared immunopathogenesis and conflicting treatment responses in this rare overlap syndrome.
The case study, accompanied by a...
09/02/2025
The Dermatologist
psoriatic arthritis
News
Real-World Data Support ITABIO Guidelines for Second-Line Biologic Use in Inflammatory Arthritis
09/02/2025
Jessica Garlewicz
The study evaluated treatment patterns and patient characteristics to assess the impact of these guidelines in real-world care.
The study evaluated treatment patterns and patient characteristics to assess the impact of these guidelines in real-world care.
The study evaluated treatment...
09/02/2025
The Dermatologist
psoriasis
News
Study Links Hypothyroidism to Psoriasis, Independent of Disease Severity
09/02/2025
Jessica Garlewicz
The findings suggest that thyroid abnormalities may represent an independent comorbidity, rather than a direct consequence of psoriasis severity.
The findings suggest that thyroid abnormalities may represent an independent comorbidity, rather than a direct consequence of psoriasis severity.
The findings suggest that...
09/02/2025
The Dermatologist
psoriasis
News
Beta-Blockers Not Linked to Increased Psoriasis Risk, Study Finds
09/02/2025
Jessica Garlewicz
A new multi-method analysis challenges long-standing concerns regarding beta-blockers and their role in triggering or worsening psoriasis.
A new multi-method analysis challenges long-standing concerns regarding beta-blockers and their role in triggering or worsening psoriasis.
A new multi-method analysis...
09/02/2025
The Dermatologist
jan/feb issue

Current Issue

January 2026
Volume 34
Issue 1
Current Issue
Issue Archive
The Dermatologist Newsletter

Recent News

skin cancer
News
Phase 3 Trial Demonstrates Significant Benefits of Libtayo in High-Risk Cutaneous Squamous Cell Carcinoma
01/14/2025
Jessica Garlewicz
Regeneron Pharmaceuticals has announced promising interim results from the Phase 3 C-POST trial, evaluating the PD-1 inhibitor Libtayo (cemiplimab).
Regeneron Pharmaceuticals has announced promising interim results from the Phase 3 C-POST trial, evaluating the PD-1 inhibitor Libtayo (cemiplimab).
Regeneron Pharmaceuticals has...
01/14/2025
The Dermatologist
doctor
News
Pongamia Pinnata Extract as a Potential Treatment for Skin Cancer
12/30/2024
Riya Gandhi, MA
New research reveals Pongamia pinnata’s powerful potential as an anti-cancer agent for skin tumors, combining traditional knowledge with cutting-edge molecular science.
New research reveals Pongamia pinnata’s powerful potential as an anti-cancer agent for skin tumors, combining traditional knowledge with cutting-edge molecular science.
New research reveals Pongamia...
12/30/2024
The Dermatologist
skin cancer
News
Non-Melanoma Skin Cancer Event Rates: Considerations for Clinical Trial Design
08/22/2024
Jessica Garlewicz
Researchers investigated clinical risk factors and event rates for the development of new non-melanoma skin cancer.
Researchers investigated clinical risk factors and event rates for the development of new non-melanoma skin cancer.
Researchers investigated...
08/22/2024
The Dermatologist
skin cancer
News
Skin Cancers Associated with Genodermatoses in Patients with Skin of Color
08/09/2024
Jessica Garlewicz
Researchers aimed to identify notable characteristics in location, frequency, and severity of cutaneous findings, along with the median age of skin cancers in patients with skin of color.
Researchers aimed to identify notable characteristics in location, frequency, and severity of cutaneous findings, along with the median age of skin cancers in patients with skin of color.
Researchers aimed to identify...
08/09/2024
The Dermatologist
skin cancer
News
Esophageal Squamous Cell Carcinoma Under Iodine Staining
08/09/2024
Jessica Garlewicz
Researchers aimed to evaluate the effects of texture and color enhancement imaging on improving the endoscopic visibility of esophageal squamous cell carcinoma under iodine staining.
Researchers aimed to evaluate the effects of texture and color enhancement imaging on improving the endoscopic visibility of esophageal squamous cell carcinoma under iodine staining.
Researchers aimed to evaluate...
08/09/2024
The Dermatologist
skin cancer
News
Establishing a Novel Model for Studying Neural Invasion in Non-Melanoma Skin Cancer
05/15/2024
Jessica Garlewicz
Researchers aimed to develop a 3-dimensional model of neural invasion in squamous cell carcinoma to better understand its underlying biologic mechanisms, which are still poorly understood.
Researchers aimed to develop a 3-dimensional model of neural invasion in squamous cell carcinoma to better understand its underlying biologic mechanisms, which are still poorly understood.
Researchers aimed to develop a...
05/15/2024
The Dermatologist
skin cancer
News
Interferon-Gamma as a Prognostic Marker in Macroscopic Stage III Melanoma
05/08/2024
Jessica Garlewicz
Researchers aimed to identify prognostic and predictive biomarkers for adjuvant anti-PD-1 therapy in patients with macroscopic stage III melanoma.
Researchers aimed to identify prognostic and predictive biomarkers for adjuvant anti-PD-1 therapy in patients with macroscopic stage III melanoma.
Researchers aimed to identify...
05/08/2024
The Dermatologist
skin cancer
News
Relationship Between Insulin Use, Social Determinants of Health, and Non-Melanoma Skin Cancer
05/07/2024
Jessica Garlewicz
Researchers aimed to investigate the relationship between insulin use, social determinants of health, and non-melanoma skin cancer risk among individuals with diabetes.
Researchers aimed to investigate the relationship between insulin use, social determinants of health, and non-melanoma skin cancer risk among individuals with diabetes.
Researchers aimed to investigate...
05/07/2024
The Dermatologist
skin cancer
News
Regulatory T Cell Involvement in Melanoma Prognosis and Treatment Strategy
03/28/2024
Jessica Garlewicz
Researchers analyzed single-cell RNA sequencing data alongside clinical information.
Researchers analyzed single-cell RNA sequencing data alongside clinical information.
Researchers analyzed single-cell...
03/28/2024
The Dermatologist
skin cancer
News
Role of Cuproptosis and Hippo Pathway in the Prognosis of Skin Cutaneous Melanoma
03/28/2024
Jessica Garlewicz
Researchers examined the correlation between cuproptosis-related and Hippo pathway-related genes and melanoma prognosis using public databases and experimental validation.
Researchers examined the correlation between cuproptosis-related and Hippo pathway-related genes and melanoma prognosis using public databases and experimental validation.
Researchers examined the...
03/28/2024
The Dermatologist
psoriasis
News
Low Prevalence but Meaningful Impact of Psychological Symptoms Seen in Well-Controlled Psoriasis
02/03/2026
Jessica Garlewicz
Anxiety and depression symptoms can still occur in young adults with well-controlled psoriasis, even when disease activity is minimal, according to a cross-sectional study exploring psychological distress and its potential biological...
Anxiety and depression symptoms can still occur in young adults with well-controlled psoriasis, even when disease activity is minimal, according to a cross-sectional study exploring psychological distress and its potential biological...
Anxiety and depression symptoms...
02/03/2026
The Dermatologist
psoriasis
News
Mathematical Modeling Study Highlights Cytokine Balance and Stem Cell Feedback in Psoriasis Control
01/22/2026
Jessica Garlewicz
A new systems biology study using mathematical modeling provides insight into how cytokine imbalance drives psoriasis flares and suggests that restoring immune-epidermal feedback.
A new systems biology study using mathematical modeling provides insight into how cytokine imbalance drives psoriasis flares and suggests that restoring immune-epidermal feedback.
A new systems biology study...
01/22/2026
The Dermatologist
Cutaneous Squamous Cell Carcinoma
News
Managing Cutaneous Squamous Cell Carcinoma
01/06/2026
Jessica Garlewicz
An updated evidence-based review outlines contemporary strategies for evaluating and managing cutaneous squamous cell carcinoma.
An updated evidence-based review outlines contemporary strategies for evaluating and managing cutaneous squamous cell carcinoma.
An updated evidence-based review...
01/06/2026
The Dermatologist
Atopic dermatitis
FDA Alerts
FDA Approves Roflumilast Cream 0.05% for Treatment of Atopic Dermatitis in Children Aged 2 to 5
10/06/2025
Riya Gandhi, MA
On October 6, 2025, the US FDA approved ZORYVE (roflumilast) cream 0.05% for the topical treatment of mild-to-moderate atopic dermatitis in pediatric patients aged 2 to 5 years.
On October 6, 2025, the US FDA approved ZORYVE (roflumilast) cream 0.05% for the topical treatment of mild-to-moderate atopic dermatitis in pediatric patients aged 2 to 5 years.
On October 6, 2025, the US FDA...
10/06/2025
The Dermatologist
AD
FDA Alerts
FDA Approves Opzelura for Atopic Dermatitis in Children Aged 2–11
09/18/2025
Riya Gandhi, MA
US FDA approved Opzelura (ruxolitinib) cream 1.5% for the short-term and noncontinuous chronic treatment of mild-to-moderate AD in nonimmunocompromised children aged 2 years and older.
US FDA approved Opzelura (ruxolitinib) cream 1.5% for the short-term and noncontinuous chronic treatment of mild-to-moderate AD in nonimmunocompromised children aged 2 years and older.
US FDA approved Opzelura...
09/18/2025
The Dermatologist
FDA Alerts
Anzupgo Available for Prescribing Today
09/08/2025
Coleen Stern, MA
FDA recently approved delgocitinib cream as the first and only treatment indicated for moderate-to-severe chronic hand eczema in adults.
FDA recently approved delgocitinib cream as the first and only treatment indicated for moderate-to-severe chronic hand eczema in adults.
FDA recently approved...
09/08/2025
The Dermatologist
psoriatic arthritis
News
Rare Case Highlights Diagnostic and Treatment Challenges in PsA–Myopathy Overlap
09/02/2025
Jessica Garlewicz
The case study, accompanied by a review of 17 similar reports, details shared immunopathogenesis and conflicting treatment responses in this rare overlap syndrome.
The case study, accompanied by a review of 17 similar reports, details shared immunopathogenesis and conflicting treatment responses in this rare overlap syndrome.
The case study, accompanied by a...
09/02/2025
The Dermatologist
psoriatic arthritis
News
Real-World Data Support ITABIO Guidelines for Second-Line Biologic Use in Inflammatory Arthritis
09/02/2025
Jessica Garlewicz
The study evaluated treatment patterns and patient characteristics to assess the impact of these guidelines in real-world care.
The study evaluated treatment patterns and patient characteristics to assess the impact of these guidelines in real-world care.
The study evaluated treatment...
09/02/2025
The Dermatologist
psoriasis
News
Study Links Hypothyroidism to Psoriasis, Independent of Disease Severity
09/02/2025
Jessica Garlewicz
The findings suggest that thyroid abnormalities may represent an independent comorbidity, rather than a direct consequence of psoriasis severity.
The findings suggest that thyroid abnormalities may represent an independent comorbidity, rather than a direct consequence of psoriasis severity.
The findings suggest that...
09/02/2025
The Dermatologist
psoriasis
News
Beta-Blockers Not Linked to Increased Psoriasis Risk, Study Finds
09/02/2025
Jessica Garlewicz
A new multi-method analysis challenges long-standing concerns regarding beta-blockers and their role in triggering or worsening psoriasis.
A new multi-method analysis challenges long-standing concerns regarding beta-blockers and their role in triggering or worsening psoriasis.
A new multi-method analysis...
09/02/2025
The Dermatologist

HMP Global Products

Events

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2026 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Terms of Use